IMU
IMUGENE FPO [IMU]
Healthcare · ASX Small Cap
$0.2120 -11.7%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 3 consecutive scans→ Score -1First seen: 2026-02-25
Score Breakdown
Technical39
Catalyst53
Sentiment50
Fundamental43
Momentum18
Risk Gate47
Active Signals
Bullish Signals
- RSI oversold (potential bounce)
- Stochastic oversold
- Price at lower Bollinger Band (oversold)
- Bollinger squeeze (breakout building)
- Sharp 5-day decline (-16.9%)
- Critical cash runway (0.9 quarters)
- Revenue in sharp decline (-36%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (0% of range)
- Small-cap ($20-100M)
- Severe 12-1 momentum decline (-66%)
- Poor risk-adjusted momentum (Sharpe -1.5)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE1 (est. 2024-03-20)
Risk Signals
- MACD bearish crossover
- Price below MAs (downtrend)
- Breakdown below 20-day support
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-36%)
Recent Catalysts
LOW Imugene to Present at TD Cowen Annual Health Care Conference
NONE Imugene Receives $2.7M R&D Tax Refund
NONE Half Yearly Report and Accounts
NONE Notice of Expiry of Listed Options
Recent ASX Announcements
| 2026-02-26 | Imugene to Present at TD Cowen Annual Health Care Conference |
| 2026-02-25 | Imugene Receives $2.7M R&D Tax Refund |
| 2026-02-25 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-24 | Notice of Expiry of Listed Options |
| 2026-02-20 | Notification regarding unquoted securities - IMU |
Key Metrics
$68.8M
Market Cap
927K
Avg Volume
1.3x
Vol Ratio
$0.21 — $1.39
52-Week Range
2.5%
Short Interest
N/A
Cash Runway
-111.3%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 81% |
| L | Leader vs Laggard | laggard | RS: -7 |
| I | Institutional Sponsorship | weak | Inst: 6% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #79 of 119 · Sector avg: 51
View all Healthcare signals →